A detailed history of Squarepoint Ops LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 20,482 shares of DVAX stock, worth $239,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,482
Previous 12,300 66.52%
Holding current value
$239,434
Previous $138,000 65.22%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.05 - $11.61 $205,844 - $237,796
20,482 New
20,482 $228,000
Q1 2023

May 15, 2023

SELL
$9.44 - $11.88 $140,014 - $176,204
-14,832 Reduced 45.95%
17,450 $171,000
Q4 2022

Feb 14, 2023

SELL
$10.27 - $13.29 $1.15 Million - $1.48 Million
-111,594 Reduced 77.56%
32,282 $343,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $1.02 Million - $1.79 Million
102,455 Added 247.35%
143,876 $1.5 Million
Q2 2022

Aug 15, 2022

BUY
$7.45 - $12.83 $211,512 - $364,256
28,391 Added 217.89%
41,421 $521,000
Q1 2022

May 16, 2022

SELL
$9.75 - $14.44 $283,218 - $419,453
-29,048 Reduced 69.03%
13,030 $141,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $20.94 $605,556 - $962,821
-45,980 Reduced 52.22%
42,078 $592,000
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $352,357 - $762,800
-38,467 Reduced 30.4%
88,058 $1.69 Million
Q2 2021

Aug 16, 2021

BUY
$7.25 - $10.99 $207,756 - $314,929
28,656 Added 29.28%
126,525 $1.25 Million
Q1 2021

May 17, 2021

BUY
$4.57 - $11.18 $447,261 - $1.09 Million
97,869 New
97,869 $962,000
Q4 2020

Feb 16, 2021

SELL
$3.73 - $5.6 $1.33 Million - $2 Million
-357,134 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.32 - $11.7 $1.31 Million - $3.53 Million
302,115 Added 549.11%
357,134 $1.54 Million
Q2 2020

Aug 14, 2020

SELL
$2.94 - $9.1 $388,635 - $1.2 Million
-132,189 Reduced 70.61%
55,019 $488,000
Q1 2020

May 15, 2020

BUY
$2.27 - $6.2 $424,962 - $1.16 Million
187,208 New
187,208 $661,000
Q2 2019

Aug 14, 2019

SELL
$3.65 - $7.89 $53,713 - $116,109
-14,716 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$7.08 - $12.09 $44,058 - $75,236
-6,223 Reduced 29.72%
14,716 $108,000
Q4 2018

Feb 14, 2019

BUY
$8.14 - $13.28 $24,273 - $39,600
2,982 Added 16.61%
20,939 $192,000
Q3 2018

Nov 14, 2018

SELL
$11.85 - $16.0 $300,314 - $405,488
-25,343 Reduced 58.53%
17,957 $223,000
Q2 2018

Aug 14, 2018

BUY
$15.15 - $20.75 $655,995 - $898,475
43,300 New
43,300 $660,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.48B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.